T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis

BP180 is the autoantigen of different immunobullous diseases, including bullous pemphigoid (BP) and pemphigoid gestationis (PG). Previously, we demonstrated that the NC16A domain of this autoantigen harbors key epitopes of autoantibodies and T cells, indicating that it plays an essential role in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.) Fla.), 2004-11, Vol.113 (2), p.179-186
Hauptverfasser: Hacker-Foegen, Mary K., Zillikens, Detlef, Giudice, George J., Lin, Mong-Shang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 186
container_issue 2
container_start_page 179
container_title Clinical immunology (Orlando, Fla.)
container_volume 113
creator Hacker-Foegen, Mary K.
Zillikens, Detlef
Giudice, George J.
Lin, Mong-Shang
description BP180 is the autoantigen of different immunobullous diseases, including bullous pemphigoid (BP) and pemphigoid gestationis (PG). Previously, we demonstrated that the NC16A domain of this autoantigen harbors key epitopes of autoantibodies and T cells, indicating that it plays an essential role in the pathogenesis of diseases. Moreover, NC16A-specific T cell clones derived from these patients were shown to express a CD4+ memory T cell phenotype and secrete cytokines that may promote autoantibody production. In this study, we further characterize the properties of these T cells by analyzing their epitope specificity and T cell receptor (TCR) gene usage. We discovered that 83% of T cell clones obtained from BP patients preferentially express TCRBV13, while clones derived from a PG patient express the TCRBV3 gene. However, no preferential TCRBJ gene usage was identified. In conclusion, our results provide an advanced understanding of the characteristics of autoimmune T cells in immunobullous diseases.
doi_str_mv 10.1016/j.clim.2004.08.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66914922</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1521661604002438</els_id><sourcerecordid>17788109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-a9b9c5394dd619be7da99839ef074ff27e19f6ba96c31855a36c0004e2b61393</originalsourceid><addsrcrecordid>eNqFkU2L1TAUhosozjj6B1xINrprzUmatAE3OvgFA7q4-5CmJ3dyaZuatMrFP2_KLYwrXSWB55y85zxF8RJoBRTk21NlBz9WjNK6om1FKX9UXINgUDaUi8f7XUqQV8WzlE6UUsGYfFpcgagF1I24Ln4fiMVhIBEtzkuI5IgTkjWZI5LgyIfv0NIyzWi985YcyHAe5_tgzwsm4mIYyWwWj9OSyC-_3JNuHYawJjJjxvwx-J6Yqf_7ecS05JIw-fS8eOLMkPDFft4Uh08fD7dfyrtvn7_evr8rbQ18KY3qlBVc1X0vQXXY9Eaplit0tKmdYw2CcrIzSloOrRCGS5tHrZF1ErjiN8WbS9s5hh9r_l6PPm1DmwlzVi2lglox9l8QmqZtgW4d2QW0MaQU0ek5-tHEswaqNzX6pDc1elOjaauzmlz0au--diP2DyW7iwy83gGTrBlcNJP16YGT0HBZbzHfXTjMO_vpMepkswKLvc8WF90H_68cfwCO_q16</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17788109</pqid></control><display><type>article</type><title>T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hacker-Foegen, Mary K. ; Zillikens, Detlef ; Giudice, George J. ; Lin, Mong-Shang</creator><creatorcontrib>Hacker-Foegen, Mary K. ; Zillikens, Detlef ; Giudice, George J. ; Lin, Mong-Shang</creatorcontrib><description>BP180 is the autoantigen of different immunobullous diseases, including bullous pemphigoid (BP) and pemphigoid gestationis (PG). Previously, we demonstrated that the NC16A domain of this autoantigen harbors key epitopes of autoantibodies and T cells, indicating that it plays an essential role in the pathogenesis of diseases. Moreover, NC16A-specific T cell clones derived from these patients were shown to express a CD4+ memory T cell phenotype and secrete cytokines that may promote autoantibody production. In this study, we further characterize the properties of these T cells by analyzing their epitope specificity and T cell receptor (TCR) gene usage. We discovered that 83% of T cell clones obtained from BP patients preferentially express TCRBV13, while clones derived from a PG patient express the TCRBV3 gene. However, no preferential TCRBJ gene usage was identified. In conclusion, our results provide an advanced understanding of the characteristics of autoimmune T cells in immunobullous diseases.</description><identifier>ISSN: 1521-6616</identifier><identifier>EISSN: 1521-7035</identifier><identifier>DOI: 10.1016/j.clim.2004.08.003</identifier><identifier>PMID: 15451475</identifier><identifier>CODEN: CLIIFY</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Autoantigens - immunology ; Autoimmunity ; Base Sequence ; Biological and medical sciences ; BP180 ; Cells, Cultured ; Clone Cells ; Collagen Type XVII ; Epitope Mapping ; Epitopes, T-Lymphocyte - immunology ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Genes, T-Cell Receptor ; Humans ; Immunopathology ; Medical sciences ; Molecular Sequence Data ; Non-Fibrillar Collagens - immunology ; Pemphigoid ; Pemphigoid, Bullous - immunology ; Polymerase Chain Reaction ; Receptors, Antigen, T-Cell, alpha-beta - genetics ; T cell receptor ; T-Lymphocytes - immunology</subject><ispartof>Clinical immunology (Orlando, Fla.), 2004-11, Vol.113 (2), p.179-186</ispartof><rights>2004 Elsevier Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-a9b9c5394dd619be7da99839ef074ff27e19f6ba96c31855a36c0004e2b61393</citedby><cites>FETCH-LOGICAL-c413t-a9b9c5394dd619be7da99839ef074ff27e19f6ba96c31855a36c0004e2b61393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1521661604002438$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16173642$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15451475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hacker-Foegen, Mary K.</creatorcontrib><creatorcontrib>Zillikens, Detlef</creatorcontrib><creatorcontrib>Giudice, George J.</creatorcontrib><creatorcontrib>Lin, Mong-Shang</creatorcontrib><title>T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis</title><title>Clinical immunology (Orlando, Fla.)</title><addtitle>Clin Immunol</addtitle><description>BP180 is the autoantigen of different immunobullous diseases, including bullous pemphigoid (BP) and pemphigoid gestationis (PG). Previously, we demonstrated that the NC16A domain of this autoantigen harbors key epitopes of autoantibodies and T cells, indicating that it plays an essential role in the pathogenesis of diseases. Moreover, NC16A-specific T cell clones derived from these patients were shown to express a CD4+ memory T cell phenotype and secrete cytokines that may promote autoantibody production. In this study, we further characterize the properties of these T cells by analyzing their epitope specificity and T cell receptor (TCR) gene usage. We discovered that 83% of T cell clones obtained from BP patients preferentially express TCRBV13, while clones derived from a PG patient express the TCRBV3 gene. However, no preferential TCRBJ gene usage was identified. In conclusion, our results provide an advanced understanding of the characteristics of autoimmune T cells in immunobullous diseases.</description><subject>Amino Acid Sequence</subject><subject>Autoantigens - immunology</subject><subject>Autoimmunity</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>BP180</subject><subject>Cells, Cultured</subject><subject>Clone Cells</subject><subject>Collagen Type XVII</subject><subject>Epitope Mapping</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Genes, T-Cell Receptor</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Non-Fibrillar Collagens - immunology</subject><subject>Pemphigoid</subject><subject>Pemphigoid, Bullous - immunology</subject><subject>Polymerase Chain Reaction</subject><subject>Receptors, Antigen, T-Cell, alpha-beta - genetics</subject><subject>T cell receptor</subject><subject>T-Lymphocytes - immunology</subject><issn>1521-6616</issn><issn>1521-7035</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2L1TAUhosozjj6B1xINrprzUmatAE3OvgFA7q4-5CmJ3dyaZuatMrFP2_KLYwrXSWB55y85zxF8RJoBRTk21NlBz9WjNK6om1FKX9UXINgUDaUi8f7XUqQV8WzlE6UUsGYfFpcgagF1I24Ln4fiMVhIBEtzkuI5IgTkjWZI5LgyIfv0NIyzWi985YcyHAe5_tgzwsm4mIYyWwWj9OSyC-_3JNuHYawJjJjxvwx-J6Yqf_7ecS05JIw-fS8eOLMkPDFft4Uh08fD7dfyrtvn7_evr8rbQ18KY3qlBVc1X0vQXXY9Eaplit0tKmdYw2CcrIzSloOrRCGS5tHrZF1ErjiN8WbS9s5hh9r_l6PPm1DmwlzVi2lglox9l8QmqZtgW4d2QW0MaQU0ek5-tHEswaqNzX6pDc1elOjaauzmlz0au--diP2DyW7iwy83gGTrBlcNJP16YGT0HBZbzHfXTjMO_vpMepkswKLvc8WF90H_68cfwCO_q16</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>Hacker-Foegen, Mary K.</creator><creator>Zillikens, Detlef</creator><creator>Giudice, George J.</creator><creator>Lin, Mong-Shang</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20041101</creationdate><title>T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis</title><author>Hacker-Foegen, Mary K. ; Zillikens, Detlef ; Giudice, George J. ; Lin, Mong-Shang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-a9b9c5394dd619be7da99839ef074ff27e19f6ba96c31855a36c0004e2b61393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Amino Acid Sequence</topic><topic>Autoantigens - immunology</topic><topic>Autoimmunity</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>BP180</topic><topic>Cells, Cultured</topic><topic>Clone Cells</topic><topic>Collagen Type XVII</topic><topic>Epitope Mapping</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Genes, T-Cell Receptor</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Non-Fibrillar Collagens - immunology</topic><topic>Pemphigoid</topic><topic>Pemphigoid, Bullous - immunology</topic><topic>Polymerase Chain Reaction</topic><topic>Receptors, Antigen, T-Cell, alpha-beta - genetics</topic><topic>T cell receptor</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hacker-Foegen, Mary K.</creatorcontrib><creatorcontrib>Zillikens, Detlef</creatorcontrib><creatorcontrib>Giudice, George J.</creatorcontrib><creatorcontrib>Lin, Mong-Shang</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical immunology (Orlando, Fla.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hacker-Foegen, Mary K.</au><au>Zillikens, Detlef</au><au>Giudice, George J.</au><au>Lin, Mong-Shang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis</atitle><jtitle>Clinical immunology (Orlando, Fla.)</jtitle><addtitle>Clin Immunol</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>113</volume><issue>2</issue><spage>179</spage><epage>186</epage><pages>179-186</pages><issn>1521-6616</issn><eissn>1521-7035</eissn><coden>CLIIFY</coden><abstract>BP180 is the autoantigen of different immunobullous diseases, including bullous pemphigoid (BP) and pemphigoid gestationis (PG). Previously, we demonstrated that the NC16A domain of this autoantigen harbors key epitopes of autoantibodies and T cells, indicating that it plays an essential role in the pathogenesis of diseases. Moreover, NC16A-specific T cell clones derived from these patients were shown to express a CD4+ memory T cell phenotype and secrete cytokines that may promote autoantibody production. In this study, we further characterize the properties of these T cells by analyzing their epitope specificity and T cell receptor (TCR) gene usage. We discovered that 83% of T cell clones obtained from BP patients preferentially express TCRBV13, while clones derived from a PG patient express the TCRBV3 gene. However, no preferential TCRBJ gene usage was identified. In conclusion, our results provide an advanced understanding of the characteristics of autoimmune T cells in immunobullous diseases.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>15451475</pmid><doi>10.1016/j.clim.2004.08.003</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1521-6616
ispartof Clinical immunology (Orlando, Fla.), 2004-11, Vol.113 (2), p.179-186
issn 1521-6616
1521-7035
language eng
recordid cdi_proquest_miscellaneous_66914922
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amino Acid Sequence
Autoantigens - immunology
Autoimmunity
Base Sequence
Biological and medical sciences
BP180
Cells, Cultured
Clone Cells
Collagen Type XVII
Epitope Mapping
Epitopes, T-Lymphocyte - immunology
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Genes, T-Cell Receptor
Humans
Immunopathology
Medical sciences
Molecular Sequence Data
Non-Fibrillar Collagens - immunology
Pemphigoid
Pemphigoid, Bullous - immunology
Polymerase Chain Reaction
Receptors, Antigen, T-Cell, alpha-beta - genetics
T cell receptor
T-Lymphocytes - immunology
title T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A43%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T%20cell%20receptor%20gene%20usage%20of%20BP180-specific%20T%20lymphocytes%20from%20patients%20with%20bullous%20pemphigoid%20and%20pemphigoid%20gestationis&rft.jtitle=Clinical%20immunology%20(Orlando,%20Fla.)&rft.au=Hacker-Foegen,%20Mary%20K.&rft.date=2004-11-01&rft.volume=113&rft.issue=2&rft.spage=179&rft.epage=186&rft.pages=179-186&rft.issn=1521-6616&rft.eissn=1521-7035&rft.coden=CLIIFY&rft_id=info:doi/10.1016/j.clim.2004.08.003&rft_dat=%3Cproquest_cross%3E17788109%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17788109&rft_id=info:pmid/15451475&rft_els_id=S1521661604002438&rfr_iscdi=true